ArticleAnnals of medicine and surgery (2012)2026

Rilzabrutinib in immune thrombocytopenia: a targeted, patient-centered alternative to conventional therapies.

Haris Afridi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.